Metagenomi Claimed Company
Metagenomi is a gene editing company committed to developing potentially curative therapeutics by leveraging a proprietary toolbox of next-generation gene editing systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. We adapt and forge these naturally evolved systems into powerful therapeutic tools that can be leveraged by partners and fuel our own pipeline of novel medicines. read more
HR or Marketing? Claim Your Free Employer Account
Christine Foster — Chief Business Officer at Metagenomi
Executive Bio
Christine has more than 30 years of pharmaceutical industry experience both in biotech and large pharma. As CBO at Metagenomi, Christine oversees all facets of new business ventures, partnerships, collaborations, and licensing deals.
In her previous role at Intellia, Christine built the business development and alliance management teams and accelerated Intellia’s external partnering efforts. Christine has led business development, alliance management, and corporate development activities through key phases of growth at multiple companies, including: Acceleron Pharma, Sunovion Pharmaceuticals, Inc., Teva Pharmaceuticals, Wyeth (now Pfizer), and GlaxoSmithKline.
Christine holds a Ph.D. in pharmacology from the University of Oxford and held postdoctoral fellowships at Brandeis University in neuroscience and at the University of Massachusetts Medical School in cardiovascular diseases.
In her previous role at Intellia, Christine built the business development and alliance management teams and accelerated Intellia’s external partnering efforts. Christine has led business development, alliance management, and corporate development activities through key phases of growth at multiple companies, including: Acceleron Pharma, Sunovion Pharmaceuticals, Inc., Teva Pharmaceuticals, Wyeth (now Pfizer), and GlaxoSmithKline.
Christine holds a Ph.D. in pharmacology from the University of Oxford and held postdoctoral fellowships at Brandeis University in neuroscience and at the University of Massachusetts Medical School in cardiovascular diseases.
Executive Team Culture Ratings from Metagenomi Employees
TOP
35%
Metagenomi's Executive Team scores in the Top 35%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at MetagenomiNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at MetagenomiMetagenomi's Executive Team at a Glance
Based on 3 ratings, Metagenomi's employees are satisfied with their Executive Team and give them a “B” or 76/100.
Metagenomi's Executive Team ranks in the Top 30% of other companies in San Francisco and Top 35% of other companies on Comparably that also have 51-200 Employees.
×